Tikva Allocell, a Singapore-based biotechnology startup developing engineered, allogeneic (donor-derived) cell therapies...
The next generation of cell and gene therapies is pushing manufacturing beyond the limits of conventiona...
Exosomes are rapidly emerging as one of the most promising frontiers in regenerative medicine, offering the therapeutic ...
JCR Pharmaceuticals Co., a global specialty biopharmaceutical company dedicated to developing therapies for rare and gen...
South Korea-based Seegene, Inc., a global leader in molecular diagnostics, has announced that its US subsidiary, Seegene...
As BIO Asia–Taiwan 2026 brought the region’s biotechnology and healthcare ecosystem together in Taip...
Fangzhou Inc. has announced the launch of Kyinsu®, the world's first once-weekly basal insulin/GLP-1 RA combination ...
South Korea-based Samsung Biologics has announced the launch of an all-cash public tender offer to acquire 100% of the f...
Galderma has announced the launch of Alastin – its premium regenerative skincare brand – across the JPAC reg...
Merck, a leading science and technology company, has opened a new €25 million BioReliance® testing facility at ...
Menarini Asia-Pacific has announced an exclusive partnership with Pharmacosmos A/S to register, commercialise and distri...
AstraZeneca has entered into an exclusive license agreement with China-based Dizal Pharmaceutical for Zegfrovy ...
India's Sai Parenterals has announced that its Australian subsidiary, Noumed Pharmaceuticals, has successfully renewed i...
How does CT fit into your overall regional expansion strategy, especially in emerging markets like India and Southeast A...
Canada-based ExCellThera Inc., a global leader in blood stem cell expansion and metabolic fitness technologies and paren...
Drug development is approaching a significant inflection point. Advances in induced pluripotent stem cells (iPSCs), orga...
Japan-based Dai Nippon Printing (DNP) has signed a share purchase agreement to acquire Kyowa Pharma Chemical, an act...
US-based Organon, a global healthcare company with deep expertise in biosimilars, and Korea's Samsung Bioepis have annou...
Cell therapy is approaching a defining transition: from highly specialised science to a reproducible, scalable pharmaceu...
The pharmaceutical industry’s innovation equation is changing. Developing an entirely new molecu...
The global CDMO market is moving beyond the era when manufacturing capacity alone defined competitive ...
As BioSpectrum Asia reports on the ground from BIO Asia–Taiwan 2026, being held from July 15–19 in T...
Telix Pharmaceuticals has officially opened a multi-million dollar radiopharmaceutical research, manufacturing and treat...
Insilico Medicine, a Hong Kong-based clinical-stage generative artificial intelligence (AI)-driven drug discovery compan...
As gene therapy moves from scientific promise towards a new phase of commercial maturity, manufacturing has emerged as o...
